New CMS Section 111 Reporting Alert
2 MIN READ
On the heels of CMS announcing July 2020 plans to upgrade the MSP Portal to allow authorized users to view and print correspondence, CMS has issued a new alert reminding Responsible Reporting Entities (RRE’s) of the importance of accurately reporting both Med Pay and Personal Injury Protection (PIP) coverage.
COVID-19 Effects on Workers’ Compensation Technologies
There is no shortage of information discussing how the COVID-19 pandemic has already changed the world as we knew it. Statista reports that the majority of Americans have significantly changed their lifestyles, with 75% reporting they’re staying home more, 54% traveling less and 51% shopping online more.
Top-Ranking Drug Classes in 2019
5 MIN READ
As part of our annual drug trends series, we’re taking a deeper dive into some of the therapeutic classes showing the biggest increases among the top 10 ranked by cost from our 2019 analysis.
Increase Your IME IQ [eBook]
1 MIN READ
Are you getting the greatest value from your independent medical examinations (IMEs)? When faced with uncertainty about specific determinations on a case, an IME can be requested to help
Making Telemedicine Work for the Tech Deficient
1 MIN READ
When a claimant doesn’t have the right technology for a telemedicine appointment, claim and treatment delays ensue. But, in a pandemic world, what can be done to prevent it?
Impact of Masks on the Deaf Community
4 MIN READ
While everyone has been affected by the COVID-19 pandemic in one way or another, the deafblind community has been affected in a detrimental way that most people may not have considered. With the already existing communication challenges, wearing masks has added yet another complicated barrier to communication between hearing and hearing impaired, hard of hearing, deaf and deafblind people.
Opioid Trends Continue to Decline in 2019
1 MIN READ
First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED.